Compare

Varex/$VREX

1D1W1M3M6MYTD1Y5YMAX

About Varex

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Ticker
$VREX
Sector
Health
Primary listing
NASDAQ
Employees
2,500

Varex Metrics

BasicAdvanced
$776M
35.44
$0.52
0.96
-

What the Analysts think about Varex

Analyst ratings (Buy, Hold, Sell) for Varex stock.
Analyst projections of the future price of Varex stock.

Bulls say / Bears say

Teledyne has agreed to buy Varex for $18.90 a share in cash, and Varex shareholders approved the deal on 28 October. That offers a defined takeover value, although regulatory clearances are still required. (Reuters, StockTitan)
Industrial revenue rose 25.6% in the third quarter, led by inspection products, while overall revenue increased 4%. Continued growth in cargo and vehicle inspection could help offset pressure elsewhere. (Varex Imaging, SEC)
The new Waygate Technologies partnership gives Varex access to a broad international sales and service network for its industrial detectors. It could help accelerate the shift from film to digital inspection and widen Varex’s reach. (Baker Hughes)
Medical revenue, Varex’s larger segment, fell 5.7% in the third quarter. If this weakness persists, industrial growth may not be enough to lift the business consistently. (SEC)
A roughly $10 million tariff-related benefit boosted third-quarter gross profit, so reported margin and earnings may overstate the strength of repeatable operations. That benefit came from refunds of costs incurred in earlier periods. (Varex Imaging)
Cash conversion is a concern: operating cash flow for the first nine months was only $3.4 million, down from $33.8 million a year earlier, while inventory rose to $347.1 million. A prolonged inventory build could keep cash tied up and strain liquidity. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 31 Oct 2026.

Varex Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Varex Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Varex

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.